… However, this adjuvant formulation fails to increase … vaccine Ag, ID93, combined with two
adjuvant formulations can lead to two different outcomes. ID93 combined with the Th1 adjuvant, …

… such as viral vectored- or protein-based vaccines. The use of recombinant … an adjuvant
inducing cell-mediated immune responses. A number of promising novel adjuvant formulations …

… Liposomes are lipid-based vesicles that self-assemble through hydrophobic interaction,
forming microparticles able to carry different vaccine or adjuvant formulations [20]. One of the …

… Subunit vaccines are promising candidates since they can … , these vaccines need adjuvants
in their formulation in order to … on adjuvants being used in new formulations of TB vaccines, …

… adjuvant formulations containing the TLR4 agonist GLA to identify candidate adjuvants to pair
with ID93, a lead TB vaccine … We evaluate a variety of adjuvant formulations including alum…

… the current state of adjuvant development and its impact on tuberculosis vaccine progress. …
for human use remains a challenge and is equally important to subunit vaccine formulation as …

… However, in these cases, the use of adjuvant is frequently required to improve their …
importance of the adjuvant in a vaccine formulation. Vaccines for tuberculosis provide an instructive …

… The failure of current BCG vaccine in controlling the global tuberculosis (TB) epidemic …
-based adjuvant formulation is an effective way to improve the immunogenicity of BCG vaccine. …

… virus (HIV) and tuberculosis. Several of these … , adjuvant formulations can be designed that
favor the development of T-helper type 1 (Th1) or type 2 (Th2) immune responses to vaccine …

… of adjuvants in the vaccine formulation. The fusion of adjuvants with Mycobacterium tuberculosis
(… the new frontier in the TB vaccine development field. Researchers have addressed this …